Editorial:Tubulin-targeted Cancer Chemotherapeutics: Advances and Challenges

E-ISSN： 1873-4294|17|22|2522-2522

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.17, Iss.22, 2017-07, pp. : 2522-2522

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ellipticines as DNA-Targeted Chemotherapeutics

Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-01 ,pp. : 575-591

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Prion Chemotherapeutics

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 1, 2009-02 ,pp. : 81-91

Bentham Science Publishers

Access to resources Recommend Favorite

EDITORIAL [Hot Topic: Molecularly Targeted Treatments for Colorectal Cancer: Advances and Limitations (Guest Editor: Silvio Parodi)]

Current Cancer Drug Targets, Vol. 12, Iss. 4, 2012-04 ,pp. : 301-302

Bentham Science Publishers

Access to resources Recommend Favorite

The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment

Current Medicinal Chemistry, Vol. 19, Iss. 25, 2012-09 ,pp. : 4218-4238

Bentham Science Publishers

Access to resources Recommend Favorite

Colchicine Semisynthetics: Chemotherapeutics for Cancer?

Current Medicinal Chemistry, Vol. 20, Iss. 7, 2013-03 ,pp. : 892-898

Bentham Science Publishers

Access to resources Recommend Favorite